These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20819526)

  • 1. Efficacy and feasibility of radiofrequency ablation for decompensated cirrhotic patients with hepatocellular carcinoma.
    Wu JY; Yang W; Cui M; Yin SS; Gao W; Wu W; Yan K; Chen MH
    Chin Med J (Engl); 2010 Aug; 123(15):1967-72. PubMed ID: 20819526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis.
    Wakuta A; Nouso K; Kariyama K; Nishimura M; Kishida M; Wada N; Mizushima T; Higashi T; Tanimoto M
    Oncology; 2011; 81(1):39-44. PubMed ID: 21912196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO; Grattagliano I; Minerva F; Pollice S; Palasciano G; Portincasa P
    J Surg Res; 2009 Dec; 157(2):199-207. PubMed ID: 19540521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
    Hirashita T; Nakashima K; Sakai M; Sakai I
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma adjacent to the diaphragm].
    Adán Merino L; Olveira Martín A; Pérez Robledo JP; Prieto I; Gea Rodriguez F; Castillo Grau P; Martín Arranz E; Alonso Gamarra E; Mora Sanz P
    Gastroenterol Hepatol; 2010 Dec; 33(10):709-15. PubMed ID: 21059478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma.
    Lencioni R; Della Pina C; Bartolozzi C
    Abdom Imaging; 2005; 30(4):401-8. PubMed ID: 16132439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
    Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB; Pilgram TK; Brown DB
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
    Lam CM; Ng KK; Poon RT; Ai V; Yuen J; Fan ST
    Br J Surg; 2004 Mar; 91(3):334-8. PubMed ID: 14991635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary assessment of utility of radiofrequency ablation technique in treatment of primary hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis.
    Witczak-Malinowska K; Zadrozny D; Studniarek M; Szurowska E; Michalska Z; Stalke P; Sikorska K; Lakomy EA
    Med Sci Monit; 2003 Aug; 9 Suppl 3():68-72. PubMed ID: 15156617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma.
    Khan MR; Poon RT; Ng KK; Chan AC; Yuen J; Tung H; Tsang J; Fan ST
    Arch Surg; 2007 Dec; 142(12):1136-43; discussion 1143. PubMed ID: 18086979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.
    Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M
    Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study.
    Latteri F; Sandonato L; Di Marco V; Parisi P; Cabibbo G; Lombardo G; Galia M; Midiri M; Latteri MA; Craxì A
    Dig Liver Dis; 2008 Aug; 40(8):684-9. PubMed ID: 18294940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.
    Montella L; Addeo R; Caraglia M; Faiola V; Guarrasi R; Vincenzi B; Palmeri A; Capasso E; Nocera V; Tarantino L; Ariete M; Martorelli A; Del Prete S
    Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.